Prosecution Insights
Last updated: April 19, 2026

Statens Serum Institut

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18004148 A DNA PLASMID SARS-CORONA VIRUS-2/COVID-19 VACCINE BUCKMASTER, MARLENE VRENI 1672 Non-Final OA Jan 03, 2023
17996379 LIPOSOMAL COMPOSITION FOR PREVENTING OR EARLY TREATMENT OF PATHOGENIC INFECTION BROWE, DAVID 1617 Final Rejection Oct 17, 2022
17207541 Methods for Evaluation of Gestational Progress and Preterm Abortion for Clinical Intervention and Applications Thereof SABOUR, GHAZAL 1686 Non-Final OA Mar 19, 2021

Managing Statens Serum Institut's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month